Knockout of SETDB1 gene using the CRISPR/cas-9 system increases migration and transforming activities via complex regulations of E-cadherin, β-catenin, STAT3, and Akt
Related Experiment Video
Updated: Dec 7, 2025

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Han-Heom Na1, Sungjin Moon1, Keun-Cheol Kim1
1Department of Biological Sciences, College of Natural Sciences, Kangwon National University, Chuncheon, 24341, Republic of Korea.
Abstract:
SETDB1 HMTase participates in various cellular processes via epigenetic transcriptional regulation. SETDB1 expression is downregulated by anticancer drug treatment in cancer cells, but we still need to verify the functional significance on SETDB1 downregulation. CRISPR/cas9 is a useful technology for doing a knockout (KO) of a target gene. It is widely used to examine the function of genes. In this study, we prepared SETDB1-KO from A549 human lung cancer cells using the CRISPR/Cas9 system, and we compared molecular changes between the A549 cells and the SETDB1-KO cells. The SETDB1-KO cell proliferation rate was slightly decreased as compared to the A549 cells, but there was no large difference in sensitivity with doxorubicin treatment. Instead, the migration activity and transforming activity were dramatically increased in SETDB-KO cells. Using a western blot analysis and an immunostaining experiment, we confirmed that SETDB1-KO downregulates the expression of E-cadherin and β-catenin. A qPCR and an RT-PCR analysis suggested that SETDB1 transcriptionally regulates E-cadherin and β-catenin. Moreover, E-cadherin expression was also detected in the cytoplasmic region of SETDB1-KO cells, indicating that functional localization of E-cadherin might be changed in SETDB1-KO cells. On the other hand, total levels of STAT3 and Akt were increased in the SETDB1-KO cells, but activation of STAT3 (pSTAT3) was not induced in doxorubicin-treated SETDB1-KO cells. SETDB1 overexpression into SETDB1-KO cells restores the expression of E-cadherin, β-catenin, STAT3, and Akt, suggesting that those proteins are tightly regulated by SETDB1. Collectively, we suggest that complex regulations on E-cadherin, β-catenin, STAT3, and Akt are correlated with the increased migration and transforming activity of SETDB1-KO cells.
Insights
SETDB1 gene knockout in lung cancer cells increases migration and transforming activity by downregulating E-cadherin and β-catenin. SETDB1 regulates key proteins involved in cancer progression.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Biology
Background:
- SETDB1 (SET Domain Bifunctional Histone Demethylase 1) is involved in epigenetic transcriptional regulation.
- SETDB1 expression decreases with anticancer drug treatment, but its functional significance remains unclear.
- CRISPR/Cas9 gene editing is a powerful tool for investigating gene function.
Purpose of the Study:
- To investigate the functional significance of SETDB1 downregulation in human lung cancer cells.
- To analyze molecular changes in A549 lung cancer cells following SETDB1 knockout (KO).
- To explore the role of SETDB1 in regulating cell proliferation, migration, and transformation.
Main Methods:
- Generated SETDB1-knockout A549 human lung cancer cells using the CRISPR/Cas9 system.
- Compared proliferation, doxorubicin sensitivity, migration, and transforming activity between wild-type and SETDB1-KO cells.
- Utilized Western blot, immunostaining, qPCR, and RT-PCR to analyze gene and protein expression, including E-cadherin, β-catenin, STAT3, and Akt.
Main Results:
- SETDB1-KO cells showed slightly decreased proliferation but no significant change in doxorubicin sensitivity.
- Migration and transforming activities were dramatically increased in SETDB1-KO cells.
- SETDB1-KO led to downregulation of E-cadherin and β-catenin, with altered E-cadherin localization. Total STAT3 and Akt levels increased, but STAT3 activation (pSTAT3) was not induced by doxorubicin.
- SETDB1 re-expression restored E-cadherin, β-catenin, STAT3, and Akt levels.
Conclusions:
- SETDB1 plays a crucial role in regulating E-cadherin, β-catenin, STAT3, and Akt expression in lung cancer cells.
- SETDB1 downregulation correlates with increased cell migration and transforming activity.
- These findings highlight SETDB1 as a potential therapeutic target in lung cancer.
More Related Videos
11:49Author Spotlight: Establishing CENP-E Knockout HeLa Cells – A Novel Approach to Study Kinesin-7 CENP-E Biology and its Inhibitors
Published on: June 23, 2023
12:19Stable Knockdown of Genes Encoding Extracellular Matrix Proteins in the C2C12 Myoblast Cell Line Using Small-Hairpin shRNA
Published on: February 12, 2020